Advent Life Sciences — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
HealthtechFremont, US
Anton Clifford(Executive Officer)James Leech(Executive Officer)Christopher Gleason(Executive Officer)Kevin K. Sidow(Executive Officer, Director)
BoardJoshua Makower(Director)
Board seatShahzad Malik· per SEC Form D
Co-investorsLightstone VenturesNew Enterprise Associates (NEA)Runway Growth CapitalGBS Venture Partners Ltd.Gilde HealthcareVertex Ventures HC
Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform.
AI & Machine LearningBiotechHealthtechMontreal, CA
Claude PerreaultPierre Thibault
Co-investorsCambridge Innovation CapitalCTI Life Sciences Fund L.P.adMare BioInnovationsFonds de solidarité FTQ
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.